INSIGHTS ON LIQUID DOSE MANUFACTURING

• Sterile Filtration Of Budesonide As A Preferred Sterilization Strategy

  Accelerate development of high‑quality inhalation therapies by leveraging sterile‑filtered budesonide to safeguard purity, stability, and patient safety.

• Commercially Proven Sterile Fill/Finish With Capacity And Global Backing

  Find comprehensive solution with new sterile fill/finish investments supporting complex molecules through robust tech transfer, commercialization expertise, and integrated cGMP manufacturing solutions.

• Barrel Filling Vs. Tip Filling A Syringe – Which Approach Should Be Used?

  There are two primary filling methods for pre-filled syringes. Explore the pros and cons of each approach, highlighting why barrel filling is generally preferred in the pharmaceutical industry.

• Redefining Prefillable Syringe System

  See how our Synchrony S1 pre-fillable syringe system delivers an integrated, system-level solution designed for performance, quality, and scalability — with simplified submissions, synchronized supply, and compatibility across the drug delivery ecosystem.

• Finding The Right Aseptic Processing Approach

  8/28/2024

  How should you approach building your aseptic processing line? Gain insight into the advantages of using a modular, configurable technology rather than custom fill-finish solutions.

• Turnkey Dismantling, Modification, And Relocation Of A Multi-Glove Isolator System

  1/30/2026

  Strategic equipment relocation and retrofitting can reduce capital costs by fifty percent and save months in lead time. Learn how to modernize legacy systems while maintaining full GMP compliance.

• Continuous Monitoring Concept

  3/5/2026

  Transitioning from periodic testing to continuous monitoring is essential for modern aseptic safety. Learn how real-time particle tracking mitigates risk and ensures compliance.

• EU GMP-Annex 1: Changes, Challenges, And Ready-To-Use Sterile Packaging

  8/27/2024

  Leveraging a pre-sterilized containment solution that meets the requirements of Annex 1 and outsources non-core activities can help prevent contamination and reduce the effort and liability of the CCS.

• Minimizing Particulate Risk

  5/13/2026

  While visible particles often draw immediate attention, visual inspection alone is insufficient, as subvisible particulate matter can pose equally significant risks to patient safety.